Clinical Trials Directory

Trials / Unknown

UnknownNCT04705688

Platelet-activation and Optimal Inhibition in Patients With Atrial Fibrillation Undergoing Left Atrial Appendage Occlusion

Platelet-activation and Optimal Inhibition in Patients With Atrial Fibrillation Undergoing Left Atrial Appendage Occlusion; The POPULAR-LAAO Trial

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
R&D Cardiologie · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The POPULAR-LAAO registry is an open-label observational prospective registry to investigate hemostatic processes following left atrial appendage occlusion.

Detailed description

This is an open-label observational prospective registry. The aim is to develop a better understanding of coagulation, platelet reactivity and prothrombotic factors in the first months after left atrial appendage occlusion, as occurrence of device-related thrombus and optimal postprocedural management remain a challenge after LAAO. The study population will consist of patients with non-valvular atrial fibrillation (AF) at risk for cardio-embolic stroke scheduled for left atrial appendage occlusion. In these patients, blood samples for coagulation and platelet reactivity testing will be taken, which will be gathered prior to the procedure and 1 day, 14 days, 3 months and 6 months after the procedure. Data will be analyzed longitudinally and between groups based on patient characteristics.

Conditions

Timeline

Start date
2021-02-24
Primary completion
2024-12-01
Completion
2024-12-01
First posted
2021-01-12
Last updated
2021-03-12

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT04705688. Inclusion in this directory is not an endorsement.

Platelet-activation and Optimal Inhibition in Patients With Atrial Fibrillation Undergoing Left Atrial Appendage Occlusi (NCT04705688) · Clinical Trials Directory